Topotecan (hycamtin): a new option for second-line treatment of advanced ovarian cancer
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia, PA
Saunders
1997
|
| Schriftenreihe: | Seminars in oncology
24,1, Suppl. 5 |
| Beschreibung: | 30 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011348955 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970521s1997 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)64165438 | ||
| 035 | |a (DE-599)BVBBV011348955 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 245 | 1 | 0 | |a Topotecan (hycamtin) |b a new option for second-line treatment of advanced ovarian cancer |c [Maurie Markman guest ed. Contributors Deborah Armstrong ...] |
| 264 | 1 | |a Philadelphia, PA |b Saunders |c 1997 | |
| 300 | |a 30 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Seminars in oncology |v 24,1, Suppl. 5 | |
| 700 | 1 | |a Markman, Maurie |e Sonstige |4 oth | |
| 700 | 1 | |a Armstrong, Deborah |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007626042 | ||
Datensatz im Suchindex
| _version_ | 1804125858749743105 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011348955 |
| ctrlnum | (OCoLC)64165438 (DE-599)BVBBV011348955 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00867nam a2200265 cb4500</leader><controlfield tag="001">BV011348955</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970521s1997 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)64165438</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011348955</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Topotecan (hycamtin)</subfield><subfield code="b">a new option for second-line treatment of advanced ovarian cancer</subfield><subfield code="c">[Maurie Markman guest ed. Contributors Deborah Armstrong ...]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, PA</subfield><subfield code="b">Saunders</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">30 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Seminars in oncology</subfield><subfield code="v">24,1, Suppl. 5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Markman, Maurie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Armstrong, Deborah</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007626042</subfield></datafield></record></collection> |
| id | DE-604.BV011348955 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:08:15Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007626042 |
| oclc_num | 64165438 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | 30 S. Ill., graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Saunders |
| record_format | marc |
| series2 | Seminars in oncology |
| spelling | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer [Maurie Markman guest ed. Contributors Deborah Armstrong ...] Philadelphia, PA Saunders 1997 30 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Seminars in oncology 24,1, Suppl. 5 Markman, Maurie Sonstige oth Armstrong, Deborah Sonstige oth |
| spellingShingle | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer |
| title | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer |
| title_auth | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer |
| title_exact_search | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer |
| title_full | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer [Maurie Markman guest ed. Contributors Deborah Armstrong ...] |
| title_fullStr | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer [Maurie Markman guest ed. Contributors Deborah Armstrong ...] |
| title_full_unstemmed | Topotecan (hycamtin) a new option for second-line treatment of advanced ovarian cancer [Maurie Markman guest ed. Contributors Deborah Armstrong ...] |
| title_short | Topotecan (hycamtin) |
| title_sort | topotecan hycamtin a new option for second line treatment of advanced ovarian cancer |
| title_sub | a new option for second-line treatment of advanced ovarian cancer |
| work_keys_str_mv | AT markmanmaurie topotecanhycamtinanewoptionforsecondlinetreatmentofadvancedovariancancer AT armstrongdeborah topotecanhycamtinanewoptionforsecondlinetreatmentofadvancedovariancancer |